FI20000403A0 - Use of GDNF family-related compounds for the preparation of testicular cancer treatment products - Google Patents
Use of GDNF family-related compounds for the preparation of testicular cancer treatment productsInfo
- Publication number
- FI20000403A0 FI20000403A0 FI20000403A FI20000403A FI20000403A0 FI 20000403 A0 FI20000403 A0 FI 20000403A0 FI 20000403 A FI20000403 A FI 20000403A FI 20000403 A FI20000403 A FI 20000403A FI 20000403 A0 FI20000403 A0 FI 20000403A0
- Authority
- FI
- Finland
- Prior art keywords
- preparation
- cancer treatment
- related compounds
- testicular cancer
- treatment products
- Prior art date
Links
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20000403A FI20000403A0 (en) | 2000-02-22 | 2000-02-22 | Use of GDNF family-related compounds for the preparation of testicular cancer treatment products |
AU2001240723A AU2001240723A1 (en) | 2000-02-22 | 2001-02-21 | The use of gdnf family-related compounds for manufacturing products for treatingtesticular tumors |
PCT/FI2001/000173 WO2001062273A1 (en) | 2000-02-22 | 2001-02-21 | The use of gdnf family-related compounds for manufacturing products for treating testicular tumors |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FI20000403A FI20000403A0 (en) | 2000-02-22 | 2000-02-22 | Use of GDNF family-related compounds for the preparation of testicular cancer treatment products |
Publications (1)
Publication Number | Publication Date |
---|---|
FI20000403A0 true FI20000403A0 (en) | 2000-02-22 |
Family
ID=8557661
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI20000403A FI20000403A0 (en) | 2000-02-22 | 2000-02-22 | Use of GDNF family-related compounds for the preparation of testicular cancer treatment products |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2001240723A1 (en) |
FI (1) | FI20000403A0 (en) |
WO (1) | WO2001062273A1 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2153843B1 (en) | 2001-09-18 | 2012-08-15 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
AU2008201996B2 (en) * | 2001-09-18 | 2011-02-10 | Genentech, Inc. | Compositions and methods for the diagnosis and treatment of tumor |
MY191934A (en) | 2010-05-20 | 2022-07-19 | Array Biopharma Inc | Macrocyclic compounds as trk kinase inhibitors |
RS61485B1 (en) | 2015-07-16 | 2021-03-31 | Array Biopharma Inc | Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors |
TWI704148B (en) | 2016-10-10 | 2020-09-11 | 美商亞雷生物製藥股份有限公司 | Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors |
JOP20190077A1 (en) | 2016-10-10 | 2019-04-09 | Array Biopharma Inc | Substituted pyrazolo[1,5-a]pyridine compounds as ret kinase inhibitors |
WO2018136663A1 (en) | 2017-01-18 | 2018-07-26 | Array Biopharma, Inc. | Ret inhibitors |
ES2948194T3 (en) | 2017-01-18 | 2023-09-01 | Array Biopharma Inc | Substituted pyrazolo[1,5-a]pyrazine compounds as RET kinase inhibitors |
JOP20190213A1 (en) | 2017-03-16 | 2019-09-16 | Array Biopharma Inc | Macrocyclic compounds as ros1 kinase inhibitors |
TWI791053B (en) | 2017-10-10 | 2023-02-01 | 美商亞雷生物製藥股份有限公司 | Crystalline forms of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile and pharmaceutical composition thereof |
TWI812649B (en) | 2017-10-10 | 2023-08-21 | 美商絡速藥業公司 | Formulations of 6-(2-hydroxy-2-methylpropoxy)-4-(6-(6-((6-methoxypyridin-3-yl)methyl)-3,6-diazabicyclo[3.1.1]heptan-3-yl)pyridin-3-yl)pyrazolo[1,5-a]pyridine-3-carbonitrile |
CN107827983B (en) * | 2017-11-06 | 2020-09-25 | 中国药科大学 | Targeting ARTN single-chain antibody, preparation method and application |
JP7061195B2 (en) | 2018-01-18 | 2022-04-27 | アレイ バイオファーマ インコーポレイテッド | Substituted pyrazolo [3,4-d] pyrimidine compound as a RET kinase inhibitor |
JP7060694B2 (en) | 2018-01-18 | 2022-04-26 | アレイ バイオファーマ インコーポレイテッド | Substituted pyrolo [2,3-D] pyrimidine compounds as RET kinase inhibitors |
CN111615514B (en) | 2018-01-18 | 2022-10-11 | 奥瑞生物药品公司 | Substituted pyrazolo [4,3-C ] pyridine compounds as RET kinase inhibitors |
CN112996794A (en) | 2018-09-10 | 2021-06-18 | 阿雷生物药品公司 | Fused heterocyclic compounds as RET kinase inhibitors |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997018240A1 (en) * | 1995-11-13 | 1997-05-22 | Carlos Ibanez | Glial cell line-derived neurotrophic factor receptors |
US6428977B1 (en) * | 1995-12-20 | 2002-08-06 | Curis, Inc. | Signalin family of TGFβ signal transduction proteins, and uses related thereto |
US6232449B1 (en) * | 1996-03-14 | 2001-05-15 | Washington University | Persephin and related growth factors |
AU763678B2 (en) * | 1998-08-21 | 2003-07-31 | Maria Lindahl | The use of glial cell line-derived neurotrophic factor family-related compounds for regulating spermatogenesis and for preparing male contraceptives |
-
2000
- 2000-02-22 FI FI20000403A patent/FI20000403A0/en unknown
-
2001
- 2001-02-21 WO PCT/FI2001/000173 patent/WO2001062273A1/en active Application Filing
- 2001-02-21 AU AU2001240723A patent/AU2001240723A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2001062273A1 (en) | 2001-08-30 |
AU2001240723A1 (en) | 2001-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI20000403A0 (en) | Use of GDNF family-related compounds for the preparation of testicular cancer treatment products | |
IL152754A0 (en) | Quinazoline derivatives for the treatment of tumours | |
EE200300497A (en) | Pyrazole derivatives for the treatment of HIV | |
PL362711A1 (en) | Morpholin-acetamide derivatives for the treatment of inflammatory diseases | |
EE04747B1 (en) | Process for the preparation of amine-platinum complexes | |
HK1068551A1 (en) | Substituted benzimidazole compounds and their use for the treatment of cancer | |
HUP0400314A3 (en) | Pharmaceutical combinations for the treatment of cancer | |
NO20024775D0 (en) | Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain | |
IS6917A (en) | Epothilone derivatives for the treatment of difficult tumors | |
NO20030163L (en) | Process for the preparation of olefins | |
DE60030554D1 (en) | USES OF ET743 FOR THE TREATMENT OF CANCER | |
AU2002240359A1 (en) | Pharmaceutical composition for the treatment of alopecia | |
EE05308B1 (en) | Process for the preparation of sulfonamide-substituted imidazotriazinones | |
FR2798664B1 (en) | PROCESS FOR THE PREPARATION OF MICROGELS OF CONTROLLED SIZE | |
NO20042640L (en) | Process for the preparation of echinocandin derivatives | |
NO20024776D0 (en) | Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain | |
NO20024777L (en) | Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain | |
NO20035538D0 (en) | Process for the preparation of zaleplon | |
ATE374011T1 (en) | SKIN TREATMENT PRODUCTS | |
EP1461030A4 (en) | Aminoalkyl-benzofuran-5-ol compounds for the treatment of glaucoma | |
NO20026155L (en) | Process for the preparation of lower olefins | |
PT1268482E (en) | PIRANOINDOIS FOR THE TREATMENT OF GLAUCOMA | |
AU2001214116A1 (en) | Novel paclitaxel derivatives for the treatment of cancer | |
NO20030515L (en) | Process for the preparation of dinapsoline | |
FI20011034A0 (en) | Process for the preparation of absorbent substances |